Ludenscheid, Germany

Richard Straube


 

Average Co-Inventor Count = 4.0

ph-index = 1


Location History:

  • Lüdenscheld, DE (2013)
  • Ludenscheid, DE (2017)

Company Filing History:


Years Active: 2013-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Richard Straube: Innovator in Peptide Research

Introduction

Richard Straube is a notable inventor based in Ludenscheid, Germany. He has made significant contributions to the field of peptide research, particularly in relation to adrenoreceptors. With a total of 2 patents, his work has implications for understanding cellular functions and potential therapeutic applications.

Latest Patents

Richard's latest patents focus on peptides that exhibit binding affinity to antibodies recognizing specific epitopes on adrenoreceptors. These peptides are characterized by an effective dose (ED) of less than 500 nm, particularly around 10 nM. The binding of these peptides to antibodies results in increased gamma-secretase activity, enhanced release of beta-amyloid molecules, and potential cellular dysfunction in cerebral blood vessel cells, glial cells, or neurons. The effectiveness of these peptides is measured through bioassays.

Career Highlights

Throughout his career, Richard has worked with prominent organizations such as the Max Delbrück Center for Molecular Medicine in Berlin-Buch and Fresenius Medical Care Deutschland GmbH. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.

Collaborations

Richard has collaborated with esteemed colleagues, including Rudolf Kunze and Gerd Wallukat. These partnerships have enriched his research endeavors and fostered innovation in peptide technology.

Conclusion

Richard Straube's work in peptide research highlights his innovative spirit and dedication to advancing scientific knowledge. His patents and collaborations reflect his commitment to addressing complex biological challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…